Procyon Corp (PCYN) financial statements (2021 and earlier)
Company profile
Business Address |
1300 S HIGHLAND AVE CLEARWATER, FL 33756 |
State of Incorp. | CO |
Fiscal Year End | June 30 |
SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
12/31/2019 TTM | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 97 | 290 | 270 | 173 | 59 | 204 | 583 | ||
Cash and cash equivalents | 97 | 290 | 270 | 173 | 59 | 204 | 583 | ||
Restricted cash and investments | 112 | 141 | |||||||
Receivables | 632 | 420 | 372 | 392 | 538 | 260 | 301 | ||
Inventory, net of allowances, customer advances and progress billings | 591 | 485 | 417 | 507 | 689 | 434 | 277 | ||
Inventory | 591 | 485 | 417 | 507 | 689 | 434 | 277 | ||
Deferred tax assets | ✕ | 243 | |||||||
Other undisclosed current assets | 434 | 398 | 325 | 166 | 455 | 454 | 444 | ||
Total current assets: | 1,753 | 1,594 | 1,384 | 1,592 | 1,882 | 1,353 | 1,605 | ||
Noncurrent Assets | |||||||||
Property, plant and equipment | 472 | 488 | 512 | 514 | 541 | 497 | 466 | ||
Deposits noncurrent assets | 4 | 1 | |||||||
Other noncurrent assets | 418 | 353 | 462 | 513 | 556 | 667 | 557 | ||
Deferred tax assets, net | ✕ | 663 | 556 | ||||||
Other undisclosed noncurrent assets | 112 | 141 | (667) | (557) | |||||
Total noncurrent assets: | 889 | 841 | 974 | 1,138 | 1,237 | 1,164 | 1,023 | ||
TOTAL ASSETS: | 2,642 | 2,435 | 2,358 | 2,730 | 3,119 | 2,516 | 2,628 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 113 | 228 | 229 | 436 | 714 | 286 | 142 | ||
Accounts payable | 113 | 121 | 358 | 121 | 112 | ||||
Accrued liabilities | 55 | 50 | 45 | 356 | 159 | 142 | |||
Employee-related liabilities | 174 | 179 | 270 | 5 | 9 | ||||
Interest and dividends payable | 0 | ||||||||
Other undisclosed accounts payable and accrued liabilities | (121) | ||||||||
Debt | 45 | 2 | 4 | 129 | 80 | ||||
Deferred revenue and credits | ✕ | ✕ | 98 | 83 | |||||
Other undisclosed current liabilities | 336 | 147 | 95 | (104) | 29 | ||||
Total current liabilities: | 494 | 376 | 326 | 440 | 843 | 361 | 254 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 12 | 2 | (4) | ||||||
Capital lease obligations | ✕ | 2 | (4) | ||||||
Operating lease, liability | 12 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
Liabilities, other than long-term debt | 555 | 663 | 558 | ||||||
Deferred revenue and credits | ✕ | ✕ | 555 | 663 | 556 | ||||
Deferred tax liabilities, net | ✕ | 0 | 1 | ||||||
Total noncurrent liabilities: | 12 | 2 | 551 | 663 | 558 | ||||
Total liabilities: | 507 | 376 | 326 | 442 | 1,394 | 1,024 | 812 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent, including: | 2,136 | 2,059 | 2,032 | 2,288 | 2,270 | 2,156 | 2,374 | ||
Common stock | 4,445 | 4,445 | 4,435 | 4,435 | |||||
Additional paid in capital | 16 | 16 | 16 | 16 | 11 | 6 | 6 | ||
Accumulated deficit | (2,452) | (2,529) | (2,556) | (2,300) | (2,312) | (2,422) | (2,204) | ||
Other undisclosed stockholders' equity attributable to parent | 127 | 127 | 137 | 137 | 4,572 | 4,572 | 4,572 | ||
Total stockholders' equity: | 2,136 | 2,059 | 2,032 | 2,288 | 2,270 | 2,156 | 2,374 | ||
Other undisclosed liabilities and equity | (545) | (663) | (558) | ||||||
TOTAL LIABILITIES AND EQUITY: | 2,642 | 2,435 | 2,358 | 2,730 | 3,119 | 2,516 | 2,628 |
Income statement (P&L) ($ in thousands)
12/31/2019 TTM | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 4,497 | 4,191 | 4,020 | 4,012 | 3,449 | 2,772 | 2,839 | |
Cost of revenue (Cost of Goods and Services Sold) | (1,243) | (1,142) | (1,085) | (1,263) | (1,030) | (1,332) | (1,185) | |
Other undisclosed gross profit | 523 | 476 | ||||||
Gross profit: | 3,254 | 3,050 | 2,936 | 2,750 | 2,419 | 1,963 | 2,130 | |
Operating expenses | (3,088) | (2,953) | (2,809) | (2,720) | (2,211) | (3,368) | (2,976) | |
Other undisclosed operating income (loss) | (312) | 1,064 | 911 | |||||
Operating income (loss): | 167 | 97 | 127 | 30 | (104) | (341) | 65 | |
Nonoperating income (expense) | 3 | 2 | 1 | (1) | 294 | 2 | 4 | |
Investment income, nonoperating | 3 | 2 | 1 | 2 | 1 | 2 | 4 | |
Interest and debt expense | (3) | (4) | (0) | |||||
Other undisclosed income from continuing operations before equity method investments, income taxes | 3 | 4 | 0 | |||||
Income (loss) from continuing operations before income taxes: | 169 | 99 | 128 | 29 | 190 | (339) | 69 | |
Income tax expense (benefit) | (78) | (72) | (383) | (17) | 81 | (121) | (45) | |
Income (loss) before gain (loss) on sale of properties: | 92 | 27 | (256) | 12 | 271 | (461) | 24 | |
Other undisclosed net income (loss) | (161) | 242 | ||||||
Net income (loss): | 92 | 27 | (256) | 12 | 110 | (218) | 24 | |
Other undisclosed net income attributable to parent | 0 | |||||||
Net income (loss) attributable to parent: | 92 | 27 | (256) | 12 | 110 | (218) | 24 | |
Preferred stock dividends and other adjustments | (17) | (17) | (18) | 13 | ||||
Other undisclosed net loss available to common stockholders, basic | (0) | (19) | (19) | (19) | ||||
Net income (loss) available to common stockholders, basic: | 75 | 10 | (273) | 26 | 90 | (238) | 4 | |
Dilutive securities, effect on basic earnings per share | 0 | |||||||
Other undisclosed net income available to common stockholders, diluted | 242 | |||||||
Net income (loss) available to common stockholders, diluted: | 75 | 10 | (273) | 26 | 90 | 4 | 4 |
Comprehensive Income ($ in thousands)
12/31/2019 TTM | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | 92 | 27 | (256) | 12 | 110 | (218) | 24 | |
Other comprehensive loss | (1) | (14) | ||||||
Comprehensive income (loss), net of tax, attributable to parent: | 92 | 27 | (256) | 12 | 110 | (220) | 9 |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.